Non-convulsive status epilepticus associated with tiagabine in a pediatric patient

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

We report a 4-year-old patient who developed non-convulsive status epilepticus (NCSE) following tiagabine (TGB) as add-on treatment for refractory partial seizures. NCSE occurred while the patient received TGB 0.83mg/kg/day. In our case, the TGB reduction led to a significant improvement of electroclinical features. The mechanisms of this abnormal effect are not clear. GABA-ergic hyperfunction and/or multiplicity of interlinked brain GABA systems associated with individual specific sensitivity could play a critical role in the pathogenesis of NCSE. This is the first report of NCSE documented by electroencephalogram (EEG) in a child under 12 years of age on TGB treatment. © 2003 Elsevier Science B.V. All rights reserved.
Original languageEnglish
Pages (from-to)518-521
Number of pages4
JournalBRAIN & DEVELOPMENT
Volume25
Publication statusPublished - 2003

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Non-convulsive status epilepticus associated with tiagabine in a pediatric patient'. Together they form a unique fingerprint.

Cite this